 |
 |
|
JOURNAL OF DIABETES AND ITS COMPLICATIONS
| |
| | |
|
|
|
|
|
|
Guide for Authors
The primary purpose of JOURNAL OF DIABETES AND ITS COMPLICATIONS is to act as
a source of information, usable
by those caring for patients with diabetes mellitus who are thereby at risk for development
of those complications which all too often
appear with time. While our primary aim is to assist the practitioner
in his/her care of such patients, and to afford access to information
that may allow the prevention of such
complications, it is the Editors? wish to function as a forum for that information which, while
still experimental,
may shed light upon current thinking of those active in the fields appropriate to the aims of JOURNAL OF DIABETES
AND ITS COMPLICATIONS.
In addition to general articles on clinical aspects of diabetes mellitus, JOURNAL OF DIABETES AND ITS COMPLICATIONS
also presents articles on basic research in all areas of diabetes and its related syndromes. Topics
covered relevant to the diabetic
patient will include diagnosis, pathogenesis, and clinical management of: diabetic
retinopathy, neuropathy and nephropathy; peripheral
vascular disease and coronary heart disease; gastrointestinal
disorders, renal failure and impotence; and hypertension and hyperlipidemia.
JOURNAL OF DIABETES AND
ITS COMPLICATIONS will also publish papers on the general pathogenesis and prevention of diabetes.
Criteria
for initial considerations for papers submitted will be originality, statistical probability of all data, and
applicability to the aims
of the Journal as a whole. Additional weight will be afforded to those submissions that are
concise and comprehensible. All potentially
acceptable manuscripts will be subjected to the process of peer review.
To aid with the peer review process, at least five suggested
reviewers whose expertise falls within the scope of
the submitted manuscript must be provided. For each suggested reviewer include full
names, addresses (physical
and email), phone and fax numbers.
To increase the usefulness of JOURNAL OF DIABETES AND ITS COMPLICATIONS
to the readership, submissions
in the following categories, IN ADDITION TO ORIGINAL MANUSCRIPTS, will be deemed appropriate for
consideration
by the Editors and Editorial Board:
Editorials: Comments by organizations or individuals on topics of current interest.
Review Articles: Critical presentations of topics of interest to those active in the prevention and treatment of
diabetes and
its long-term complications.
Case Reports: Limited to the presentation and discussion of cases that help advance our understanding
of diabetes
and related syndromes.
Letters to the Editor: Responses to previous articles and editorials.
Announcements:
Announcements to pertinent forthcoming meetings or events.
MANUSCRIPTS: Manuscripts should be typewritten, double-spaced, using
a standard sized typeface and margins
of at least one inch. Manuscripts are accepted for publication with the understanding that their
content, or
their essential substance, have not been published elsewhere, except in abstract form or by the express consent of
the Editors.
Materials taken from other sources must be accompanied by written permissions for reproduction,
obtained from the original publisher.
Statistical methods should be identified. Priority claims are discouraged.
Acknowledgements of aid or criticism should be approved by
the person whose help is being recognized.
As of April 3, 2006, all new manuscripts must be submitted through the JOURNAL OF DIABETES
AND ITS
COMPLICATIONS' (JDC) online submission and review web site ( http://ees.elsevier.com/jdc/ ). Manuscripts
submitted
prior to April 3rd will continue to be processed in the previous system and will never be part of the
online system). Authors are requested
to submit the text, tables, and artwork in electronic form to this address.
Please note that an editable file is needed for production
purposes, so please upload your text files as Word (.doc)
files, not as a PDF. In an accompanying letter, authors should state that the
manuscript, or parts of it, have not
been and will not be submitted elsewhere for publication. Authors must include a list of at least
five potential
reviewers for their manuscript, with complete contact information.
Submission items include a cover letter (a separate
file for upload), suggested reviewers, the manuscript (including title
page, abstract, manuscript text, references, and table/figure
legends), tables and figures. Revised manuscripts should
also be accompanied by a unique file (separate from the cover letter) with responses
to reviewer's comments. The
preferred order of files is as follows: cover letter, suggested reviewers, response to reviews (revised manuscripts
only),
manuscript file(s), table(s), and figure(s). Files should be labeled with appropriate and descriptive file names (for
example,
SmithText.doc, Fig1.eps, Table3.doc). Upload text, tables and graphics as separate files. Do not import figures
or tables into the
text document and do not upload your text as a PDF. Complete instructions for electronic artwork
submission can be found on the Author
Gateway, accessible through the journal home page.
Manuscripts must be written in English. The file should follow the general instructions
on style/arrangement and,
in particular, the reference style of this journal as given in the Information for Authors. The file should
be double
spaced and should use the wrap-around end-of-line feature, i.e., returns at the end of paragraphs only. Place two
returns
after every element, such as title, headings, paragraphs, figure and table callouts. Be sure to keep a
back-up disk for reference and
safety.
CONFLICT OF INTEREST POLICY: Authors are required to disclose commercial or similar relationships to
products or companies
mentioned in or related to the subject matter of the article being submitted. Sources of
funding for the article should be acknowledged
in a footnote on the title page. Affiliations of authors should
include corporate appointments relating to or in connection with products
or companies mentioned in the
article, or otherwise bearing on the subject matter thereof. Other pertinent financial relationships, such
as consultancies,
stock ownership or other equity interests or patent-licensing arrangements, should be disclosed to the
Editor-in-Chief
in the cover letter at the time of submission. Such relationships may be disclosed in the Journal at
the discretion of the Editor-in-Chief
in footnotes appearing on the title page. Questions about this policy should
be directed to the Editor-in-Chief.
TITLE PAGE:
On the title page include title; subtitle (if any); first name, middle initial, and last name of each
author, which academic degrees;
name of Department(s) and Institution(s) to which the work should be attributed;
disclaimer(s) (if any); name and address of author to
whom requests for reprints should be sent. The address,
telephone and fax numbers of the person responsible for negotiations concerning
the manuscripts should be
listed separately and clearly labeled as such. Authors will be required to sign a statement conferring the
manuscript copyright to JOURNAL OF DIABETES AND ITS COMPLICATIONS.
ABSTRACT AND KEY WORDS: An abstract of 100 to 250 words
for articles (including reviews), or 50 to 100
words for brief communications or expanded abstracts, should be typed double-spaced on
a separate page. It
should cover the main factual points, including statements of the problem, methods, results, and conclusions. The
abstract should be accompanied by a list of three of five key words for indexing purposes.
TEXT: Appropriate headings and subheadings
should be provided in the methods, results, and discussion
sections. Please keep the text clear and concise. Because the readership of
JOURNAL OF DIABETES AND ITS
COMPLICATIONS spans many disciplines, jargon should be avoided, as it may not be familiar to some readers.
ABBREVIATIONS: Use standard abbreviations and units recommended in the Style Manual for Biological Journals
(Fourth edition,
Arlington, Va., American Institute of Biological Sciences, 1978). Nonstandard abbreviations
should be defined the first time they appear
in the text. A list of abbreviations is available in "Uniform
Requirements for Manuscripts submitted to Biological Journals," Annals
of Internal Medicine 90:95-99, 1979.
DRUG NAMES: Generic names should be used. Proprietary names may be given (parenthetically)
with the first
use of the generic name.
REFERENCES: References should be cited in the text by name(s) of author(s), followed
by year of publication in
parentheses. The reference list should be typed alphabetically according to the following style:
For
Journal Articles: Vitinghus, E. & Mogensen, C. E. (1982). Graded exercise and protein excretion in diabetic man
and the effect
of insulin treatment. Kidney International, 43, 215?276.
For Books: Brownlee, M. (Ed.) (1981). Diabetes Mellitus.
New York, NY: Garland Press.
For Articles in Books: Kohner, E. M. (1981). Assessment and treatment of diabetic retinopathy. In Brownlee,
M. (Ed.),Diabetes Mellitus. (pp. 117?212): New York, NY: Garland Press.
For Government Publications: Mackay, B.
B. (Ed.) (1979). Twelfth Annual Contractors Conference of the Artificial
Kidney Program of the NIAMDD. Bethesda, Maryland: U.S. Government
Printing Office (NIH publication No.
81?1979).
Accuracy of references is the responsibility of the author(s) and should be carefully
rechecked before submission.
References that are in press must state name of journal and, if possible, volume and year. References to
unpublished
material, if essential, should be incorporated in the appropriate place in the text. Written permission from
authors of unpublished
data should be obtained and submitted.
ILLUSTRATIONS: To properly submit digital artwork, please see "Artwork Instructions"
on http://ees/elsevier.com/jdc/
for details on image formats, sizing, naming conventions, preparation, and file delivery
of your digital artwork.
Digital artwork that does not conform to these instructions will be rejected.
TABLES: Tables should
be typed, double-spaced, on separate sheets with number (Roman) and title. Symbols for units
should be confined to column headings. Abbreviations
should be kept to a minimum, and those used, explained.
REVIEW AND ACTION: All contributions (including solicited articles)
are critically reviewed by the Editors,
members of the Editorial Board, and/or appropriate consultant reviewers. Reviewers' comments
are usually
returned to authors. The decision of the Editors is final. Contact address:
Philip Raskin, MD
Editor-in-Chief
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Department of Internal Medicine
The University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390-8858, USA
E-mail: jdc@utsouthwestern.edu
|
|
|
|
| |
| | |
|
| |
